Cerebricon Ltd. is a provider of high quality and cost effective pre-clinical contract research utilising models of CNS diseases such as stroke, Parkinson's disease, Alzheimer's disease, multiple sclerosis, migraine, traumatic brain injury, spinal cord injury, Huntington's disease and ALS.
Cerebricon works as an extension of the discovery process and, when needed, as an independant validation body for the assessment of in-licensing candidates.
Broad Experience Base in the Preclinical Testing of Pharmaceuticals for CNS Diseases